evidence: Like other severe infections, COVID-19 pneumonia may induce sepsis-induced coagulopathy (SIC) and (if not controlled despite adequate medical therapy) progress to disseminated intravascular coagulation (DIC) [8]. DIC is one of the severe complications identified in patients with pneumonia, septicaemia, malignancy and other severe diseases [9]. The clinical diagnosis of DIC is made on rapid progression of serious deterioration of organ functions resulting in a boost of intravascular thrombin generation and microthrombi with secondary parenchymal bleeding through endothelial leakage [10]. Venous thromboembolism (VTE) may develop in COVID-19 patients via immunologic and toxic activation of intravascular and platelet-released thrombin [7]. The occurrence of fatal pulmonary embolism (PE) may be more frequent than that described so far and is the subject of ongoing examinations in pathology [7].